Emily Golden - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Emily Golden

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

ALTEX|December 3, 2023

Toward implementing virtual control groups in nonclinical safety studiesEmily Golden, David Allen, Alexander Amberg, et al.

The Journal of Pathology|May 15, 2026

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profileKathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.

Nature Communications|March 27, 2021

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancerEmily Golden, Rabab Rashwan, Eleanor A Woodward, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

ALTEX|December 3, 2023

Toward implementing virtual control groups in nonclinical safety studiesEmily Golden, David Allen, Alexander Amberg, et al.

The Journal of Pathology|May 15, 2026

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profileKathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.

Nature Communications|March 27, 2021

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancerEmily Golden, Rabab Rashwan, Eleanor A Woodward, et al.

Pageof 3